Amerikanische Gesellschaft für Hirudotherapie

Annexin A1: potential for glucocorticoid sparing in RA

Review published in Nature reviews. Rheumatology (2013)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Narrative reviewSicherheit & InfektionskontrolleYang YH et al. · Nature reviews. Rheumatology, 2013

Abstract

Glucocorticoids have broad-ranging and powerful anti-inflammatory and immunomodulatory effects. Unsurprisingly, therefore, glucocorticoids are widely and persistently used to treat a large number of inflammatory diseases, including rheumatoid arthritis (RA), despite the well-described adverse effects of these drugs. Annexin A1 is a glucocorticoid-induced molecule that is known to replicate many of the described anti-inflammatory effects of glucocorticoids. In addition to the well-documented roles of this protein in neutrophil function, emerging evidence suggests that annexin A1 is involved in the modulation of T-cell function and the adaptive immune responses relevant to RA. Interest in annexin A1 was renewed after the delineation of the receptors for this protein. This breakthrough also led to advances in our understanding of anti-inflammatory annexin A1 mimetic peptides and agonistic compounds targeting these receptors, particularly those specific for the receptor N-formyl peptide receptor 2 (FPR2). Herein, we review the current knowledge of the biological activities of annexin A1 and their relevance to RA pathogenesis. We also discuss the potential of annexin A1 mimics and strategies aimed at potentiating annexin A1 signalling to become viable approaches to minimizing glucocorticoid use in RA and other inflammatory disorders.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleReview
Indexed MeSH termsAdaptive ImmunityAnnexin A1Arthritis, RheumatoidGlucocorticoidsHumansReceptors, Formyl PeptideReceptors, LipoxinSignal TransductionT-Lymphocytes

Zusammenfassung

Glucocorticoids have broad-ranging and powerful anti-inflammatory and immunomodulatory effects.

Warum dies für die Hirudotherapie relevant ist

This review examines the biological activities of Annexin A1, a glucocorticoid-induced anti-inflammatory protein that modulates T-cell function, exploring its potential to minimize glucocorticoid use in treating rheumatoid arthritis. The article discusses protein mechanisms, FPR2 receptors, and Annexin A1 mimetic peptides and agonistic compounds without making any reference to leeches or leech-derived molecules. The study does not evaluate hirudotherapy. Therefore, its relevance to the American Society of Hirudotherapy is entirely indirect, limited to the broader context of anti-inflammatory therapeutic strategies.

Zitation

Annexin A1: potential for glucocorticoid sparing in RA

Yang YH et al. · Nature reviews. Rheumatology, 2013

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.